Caribou Biosciences, Inc.

CRBU

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001619856

SEC filings (opens in a new tab)

No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.

Q1 2022 vs. Q4 2021

How the institutions holding Caribou Biosciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of CRBU: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	93	1	104	+12
Shares	31.1M	16.0K	34.1M	+3.06M (+9.8%)
Value	$464.7M	$241.0K	$313.2M	−$151.3M (−32.6%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Caribou Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CRBU in Q1 2022
Institution	Shares	Value	% of portfolio
Regents of the University of California	181,304	$1.66M	0.25%
Nelson Capital Management, LLC	64,858	$595.0K	0.12%
Qube Research & Technologies Ltd	50,258	$461.0K	0.00%
UBS Asset Management Americas Inc	30,300	$278.2K	0.00%
Gsa Capital Partners LLP	25,021	$230.0K	0.03%
Occudo Quantitative Strategies LP	24,960	$229.0K	0.02%
Two Sigma Investments, LP	24,456	$225.0K	0.00%
Franklin Resources Inc	21,450	$197.0K	0.00%
Jump Financial, LLC	16,400	$151.0K	0.01%
Schonfeld Strategic Advisors LLC	14,800	$136.0K	0.00%
Erste Asset Management GmbH	13,900	$128.6K	0.00%
Trexquant Investment LP	13,981	$128.0K	0.01%
Invesco Ltd.	12,113	$110.0K	0.00%
Balyasny Asset Management LLC	11,812	$108.0K	0.00%
Barclays PLC	8,369	$77.0K	0.00%
Penserra Capital Management LLC	6,668	$61.0K	0.00%
Amalgamated Bank	4,851	$45.0K	0.00%
Amalgamated Financial Corp.	4,851	$45.0K	0.00%
Point72 Hong Kong Ltd	2,063	$19.0K	0.00%
Herold Advisors, Inc.	1,750	$16.1K	0.01%
Dark Forest Capital Management LP	1,472	$13.0K	0.00%
Allworth Financial LP	530	$5.00K	0.00%
FinTrust Capital Advisors, LLC	100	$1.00K	0.00%

Sold out (11)

Institutions that held Caribou Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CRBU in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Coatue Management LLCSuperinvestorCoatue Management	557,669	$8.41M
CloudAlpha Capital Management Limited/Hong Kong	415,000	$6.26M
Victory Capital Management Inc	81,160	$1.23M
Squarepoint Ops LLC	76,691	$1.16M
Pura Vida Investments, LLC	41,932	$633.0K
Ergoteles LLC	41,487	$626.0K
DekaBank Deutsche Girozentrale	22,000	$321.0K
Atom Investors LP	16,323	$246.0K
Royce & Associates LP	12,900	$195.0K
KCL Capital, L.P.	12,000	$181.0K
Eaton Vance Management	425	$6.00K

Not filed for Q1 2022 yet (1)

Institutions that held Caribou Biosciences, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBU in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
AlphaCentric Advisors LLC	16,000	$241.0K